Tmic-01. molecular and clinical characterization of pd-l1 expression at transcriptional level via 976 samples of brain glioma
CONCLUSION:PD-L1 is upregulated in glioblastoma, and is synergistic with other check point members. Moreover, PD-L1 is significantly associated with T-cell activation and macrophage related immune response and predicts much worse survival for patients, warranting clinical trials of PD1/PD-L1 checkpoint inhibitors for potential glioma treatment.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Wang, Z. Tags: TUMOR MICROENVIRONMENT Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Genetics | Glioma | Molecular Biology | Neurology | Statistics | Study